Related Experiment Video
Updated: Jun 8, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Activated sterol regulatory element-binding protein-2 suppresses hepatocyte nuclear factor-4-mediated Cyp3a11
Shin-ichi Inoue1, Kouichi Yoshinari, Mika Sugawara
1Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi 980-8578, Japan.
Abstract:
Sterol regulatory element-binding protein-2 (SREBP-2) is a key transcription factor for the cholesterol homeostasis. Recent studies have suggested the association of CYP3A enzymes, major drug-metabolizing enzymes, with cholesterol metabolism. In the present study, we have investigated a possible involvement of SREBP-2 in hepatic Cyp3a11 expression. Feeding a low-cholesterol diet (LCD) to mice activated hepatic SREBP-2 whereas it attenuated hepatic Cyp3a11 expression. These phenomena were reversed by cholesterol supplementation to LCD. In reporter assays, the overexpression of constitutively active SREBP-2 reduced Cyp3a11 reporter activity through the region from -1581 to -1570 of Cyp3a11. This region contained a putative hepatocyte nuclear factor-4α (HNF-4α) binding motif, and HNF-4α, but not SREBP-2, bound to the motif in in vitro binding assays. With the mutation or deletion of this motif, the SREBP-2-dependent suppression of Cyp3a11 expression disappeared in reporter assays. In pull-down assays and coimmunoprecipitation assays, SREBP-2 bound to peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α), a major coactivator for HNF-4α, via its transactivation domain and inhibited the interaction between HNF-4α and PGC-1α in vitro. A mutant SREBP-2 lacking the transactivation domain consistently failed to reduce Cyp3a11 reporter activity. Furthermore, PGC-1α overexpression relieved the SREBP-2-mediated reduction of Cyp3a11 reporter activity. Finally, chromatin immunoprecipitation assays demonstrated that the extent of PGC-1α binding to the Cyp3a11 promoter was reduced by LCD-feeding in mouse livers. In conclusion, activated SREBP-2 interacts with PGC-1α in mouse livers at reduced cholesterol intake. This results in the reduced PGC-1α recruitment to HNF-4α on the Cyp3a11 promoter and the subsequent down-regulation of Cyp3a11 expression.
Insights
Sterol regulatory element-binding protein-2 (SREBP-2) activation by low-cholesterol diets suppresses hepatic Cyp3a11 expression. SREBP-2 inhibits Cyp3a11 by binding to PGC-1α, reducing its interaction with HNF-4α on the Cyp3a11 promoter.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Sterol regulatory element-binding protein-2 (SREBP-2) is crucial for cholesterol homeostasis.
- CYP3A enzymes are key drug-metabolizing enzymes linked to cholesterol metabolism.
Purpose of the Study:
- Investigate the role of SREBP-2 in regulating hepatic Cyp3a11 expression.
- Elucidate the molecular mechanism by which SREBP-2 influences Cyp3a11 levels.
Main Methods:
- Dietary manipulation (low-cholesterol diet) in mice.
- Reporter gene assays to assess Cyp3a11 promoter activity.
- In vitro binding assays (pull-down, coimmunoprecipitation) and chromatin immunoprecipitation (ChIP).
Main Results:
- Low-cholesterol diet activated SREBP-2 and decreased Cyp3a11 expression.
- SREBP-2 suppressed Cyp3a11 reporter activity via a specific promoter region containing an HNF-4α motif.
- SREBP-2 inhibited the interaction between HNF-4α and its coactivator PGC-1α, reducing PGC-1α recruitment to the Cyp3a11 promoter.
Conclusions:
- Activated SREBP-2 down-regulates hepatic Cyp3a11 expression under low-cholesterol conditions.
- This regulation occurs through SREBP-2's interaction with PGC-1α, disrupting the HNF-4α/PGC-1α complex.
- Findings reveal a novel mechanism linking cholesterol metabolism to drug-metabolizing enzyme regulation.
More Related Videos
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of Nuclear Protein Sorting
Cell Specific Gene Expression
Master Transcription Regulators
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Co-activators and Co-repressors

